NCT07428018
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07428018
Title Pragmatic Study to Optimize Neoadjuvant Treatment and Surgical De-escalation in HR+/HER2- Early Breast Cancer Using Oncotype DX and Abemaciclib (VIOLET)
Acronym VIOLET
Recruitment Not yet recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Mario Negri Institute for Pharmacological Research
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA

Facility Status City State Zip Country Details
Istituto di Ricerche Farmacologiche Mario Negri IRCCS Milan MI 20156 Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field